Chronic Hepatitis B Infection
VIDEO: Simplified screening, treatment strategies critical in HBV
PHILADELPHIA — Paul Kwo, MD, professor of medicine at Stanford University, speaks with Healio about presentations investigating the undertreatment of hepatitis B.
ALLIANCE trial shows positive HIV/HBV coinfection treatment data
SEATTLE — The ALLIANCE trial showed positive data on bictegravir/emtricitabine/tenofovir alafenamide treatment for HIV and hepatitis B coinfection while also providing data on treatment outcome predictors.
Combined VIR-2218, VIR-3434 therapy reduces HBV surface antigen
WASHINGTON — Preliminary results showed combined VIR-2218 and VIR-3434 therapy reduced hepatitis B surface antigen with mild adverse events among a small subset of patients with chronic HBV infection.
Antiviral combination plus standard therapy achieves ‘controlled biological state’ in HBV
LONDON — Therapy combining small interfering RNA, capsid assembly modulator and nucleotide analogue reduced HBsAg levels over 24 weeks compared with standard therapy, according to a presenter at the International Liver Congress.
HBV vaccine demonstrates encouraging results in early clinical trials
A treatment regimen of low dose VBI-2601 (BRII-179) injections in patients with chronic hepatitis B exhibited positive safety, tolerability and efficacy, according to a poster presented at the International Liver Congress.